Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Summary

The main purpose of this trial is to investigate and evaluate the efficacy of cryoablation combined with camrelizumab treatment to patients with advanced or inoperable soft tissue sarcomas after standard treatment failure.

Timeline

Start

2024-11-20

Primary completion

2026-11-30

Completion

2027-11-30

Drugs

Indications